Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$216K Buy
1,681
+2
+0.1% +$234 0.03% 194
2026
Q1
$202K Sell
1,679
-377
-18% -$43.5K 0.03% 198
2025
Q4
$216K Buy
+2,056
New +$193K 0.03% 187
2025
Q2
Sell
-3,052
Closed -$274K 200
2025
Q1
$274K Sell
3,052
-61,576
-95% -$5.75M 0.05% 174
2024
Q4
$7.29M Buy
64,628
+3,176
+5% +$327K 0.65% 54
2024
Q3
$6.98M Buy
61,452
+399
+0.7% +$47.4K 1.25% 13
2024
Q2
$7.56M Sell
61,053
-587
-1% -$75.6K 1.6% 8
2024
Q1
$8.13M Sell
61,640
-871
-1% -$107K 1.7% 7
2023
Q4
$6.81M Buy
62,511
+377
+0.6% +$39.1K 1.6% 9
2023
Q3
$6.4M Buy
62,134
+1,096
+2% +$118K 1.64% 7
2023
Q2
$7.04M Sell
61,038
-741
-1% -$84.1K 1.76% 7
2023
Q1
$6.57M Buy
61,779
+302
+0.5% +$32.6K 1.73% 6
2022
Q4
$6.82M Buy
61,477
+93
+0.2% +$9.51K 1.9% 5
2022
Q3
$5.29M Buy
61,384
+1,068
+2% +$95.3K 1.65% 10
2022
Q2
$5.5M Buy
+60,316
New +$5.35M 1.63% 7
2021
Q2
Sell
-40,279
Closed -$2.96M 202
2021
Q1
$2.96M Sell
40,279
-10,579
-21% -$780K 0.89% 40
2020
Q4
$4.13M Sell
50,858
-79
-0.2% -$6.04K 1.29% 12
2020
Q3
$4.03M Buy
50,937
+917
+2% +$71.8K 1.5% 10
2020
Q2
$3.69M Sell
50,020
-9,080
-15% -$684K 1.94% 7
2020
Q1
$4.6M Buy
59,100
+4,254
+8% +$334K 2.89% 1
2019
Q4
$4.76M Sell
54,846
-2,253
-4% -$185K 2.49% 3
2019
Q3
$4.51M Buy
57,099
+11,326
+25% +$908K 2.63% 3
2019
Q2
$3.67M Buy
45,773
+132
+0.3% +$10.1K 2.04% 7
2019
Q1
$3.62M Sell
45,641
-2,279
-5% -$170K 2.1% 5
2018
Q4
$3.49M Sell
47,920
-2,580
-5% -$182K 2.36% 6
2018
Q3
$3.42M Buy
+50,500
New +$3.22M 1.94% 15

Other funds holding MRK

Oliver Luxxe Assets's MRK Position: Q2 2026 in Review

Oliver Luxxe Assets increased its Merck (MRK) stake by 0.12% in Q2 2026, buying an estimated $234 and bringing the position to 1,681 shares worth $216K. The position accounts for 0.03% of the portfolio, ranked #194.

Oliver Luxxe Assets first reported a position in MRK in Q3 2018 and has held it in 26 quarters since. The position peaked at $8.13M in Q1 2024. 924 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Oliver Luxxe Assets held 1,681 shares of Merck worth $216K as of Q2 2026.
  • Oliver Luxxe Assets bought 2 Merck shares in Q2 2026, an estimated $234.
  • Merck made up 0.03% of Oliver Luxxe Assets's portfolio in Q2 2026, its #194 holding.
  • Oliver Luxxe Assets first reported a position in Merck in Q3 2018 and has held it in 26 quarters since.
  • Oliver Luxxe Assets's Merck position peaked at $8.13M in Q1 2024.
  • 924 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.